Missouri Reglan Tardive Dyskinesia Attorneys
Reglan
Reglan (Metoclopramide) and Octamide, Maxolon, Degan, Maxeran, Primperan, and Pylomid are part of a family of medications used to treat heartburn caused by gastroesophageal reflux. Reglan and other forms of metoclopramide are taken by more than two million Americans. While Reglan is only approved for short-term use (4-12 weeks), doctors and patients were not made aware of this limited usage resulting in extended Reglan use and severe health consequences to the user.
In 2009, the FDA ordered the manufacturer to add a boxed warning about this risk to its label. Further, after studies revealing the link between metoclopramide and movement disorders, the FDA ordered the Reglan manufacturer to add a boxed warning to the labels regarding the risk of Reglan Tardive Dyskinesia associated with chronic, long-term use.
Tardive Dyskinesia is characterized by repetitive, involuntary movements. Tardive dyskinesia can continue to affect the patient even after the Reglan is discontinued. Symptoms of tardive dyskinesia may include:
- Involuntary/ repetitive movements of the extremities
- Facial tics
- Lip movements
- Face Grimacing
- Tongue protrusion
- Rapid eye movements or blinking
- Impaired movement of the fingers.
- Restless Leg Syndrome (RLS)
It is the duty of drug manufacturers to inform users and medical professionals of all known side effects and criteria for use for any drug it manufacters. If you used Reglan beyond the approved 4-12 weeks and experienced serious side effects, such as tardive dyskinesia, contact an experienced Missouri medication side effects attorney at Page Law to discuss your case - no fees unless we recover for you.
